Koers Apyx Medical Corporation
Aandelen
APYX
US03837C1062
Medische apparatuur, benodigdheden & distributie
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,32 USD | +4,76% | -5,04% | -49,62% |
05/04 | Archon Capital Management gaat in gesprek met Apyx Medical Corporation | CI |
01/04 | Stavros G. Vizirgianakis in gesprek met Apyx Medical Corporation | CI |
Omzet 2024 * | 49,94 mln. 46,66 mln. | Omzet 2025 * | 54,52 mln. 50,95 mln. | Marktkapitalisatie | 43,65 mln. 40,79 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -27 mln. -25,23 mln. | Nettowinst (verlies) 2025 * | -25 mln. -23,36 mln. | EV/omzet 2024 * | 0,87 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 0,8 x |
K/w-verhouding 2024 * |
-1,62
x | K/w-verhouding 2025 * |
-1,81
x | Werknemers | 252 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 82,08% |
Recentste transcriptie over Apyx Medical Corporation
1 dag | +4,76% | ||
1 week | -5,04% | ||
Lopende maand | -2,94% | ||
1 maand | +3,94% | ||
3 maanden | -40,81% | ||
6 maanden | -43,59% | ||
Lopend jaar | -49,62% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Charles Goodwin
CEO | Chief Executive Officer | 58 | 15-12-17 |
Andrew Makrides
FOU | Founder | 82 | 01-01-78 |
Matthew Hill
DFI | Director of Finance/CFO | 56 | 04/12 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Andrew Makrides
FOU | Founder | 82 | 01-01-78 |
Lawrence Waldman
BRD | Director/Board Member | 77 | 15-03-11 |
Craig Swandal
BRD | Director/Board Member | 63 | 09-03-18 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
23-04-24 | 1,32 | +4,76% | 54 670 |
22-04-24 | 1,26 | -4,55% | 77 365 |
19-04-24 | 1,32 | -4,35% | 56 886 |
18-04-24 | 1,38 | +4,55% | 66 774 |
17-04-24 | 1,32 | -5,04% | 89 880 |
uitgestelde koers Nasdaq, 23 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-49,62% | 43,65 mln. | |
-2,25% | 186 mld. | |
-1,32% | 107 mld. | |
-3,92% | 67,57 mld. | |
+7,99% | 50,7 mld. | |
+15,74% | 47,2 mld. | |
-0,45% | 39,72 mld. | |
+10,81% | 27,48 mld. | |
+2,34% | 25,65 mld. | |
+13,37% | 24,97 mld. |